Navigation Links
Biopsy-Cut® Biopsy Needles

ProductsBiopsy-Cut® Biopsy Needles
Company C. R. Bard, Inc.
Item Biopsy-Cut® Biopsy Needles
Features 
  • Extremely sharp needle trocar to collect consistently superior core samples with minimal crush
  • Choice of penetration depths to access testicular and seminal vesical biopsies
  • Etched needle tip for better visualization of needle placement under ultrasound guidance
  • Color-coded hubs for easy identification
Description Every Bard® Biopsy Instrument and Needle is specially designed to help you achieve one important goal: a large quality, reliable core sample. All needles are engineered for exceptional performance, featuring ultra-sharp tips and polished surfaces for smooth entry and exit. A broad selection of biopsy systems and needle sizes assures an ideal match with procedural needs and personal preferences.
Info C. R. Bard, Inc.
Customer Service: (800) 367-2273
Web site: http://www.crbard.com

Related medicine products :

1. Madlab Biopsy Forceps
2. Michele Vertebral Biopsy Trephine
3. BIPAL Biopsy Forceps
4. Pointed Biopsy Grasping Forceps
5. MultAcoice™ Biopsy Forceps
6. MultAcoice™ Biopsy Forceps with Teeth
7. Breast Biopsy Guard
8. TargetScan Targeted Prostate Biopsy System
9. Cup Biopsy Forceps
10. Brush Biopsy Sets
11. Deflectable Brush Biopsy Sets
CELL-DYN Sapphire, our flagship solution for high-volume laboratories, utilizes patented MAPSS plus 3-color fluorescent technology for improved lab efficiency....
... IMMULITE 2500 is a high-throughput immunoassay ... ,of the IMMULITE 2000 with the important ... technology ,allows assays to be designed for ... times. ,This allows for critical assays such ...
... sulfate ester of DHEA, derived from sulfated ... in adrenal and extradrenal tissues. DHEA is ... adrenal cortex, and is a precursor for ... weak androgenic activity, which for unsulfated DHEA ...
... DSL's unique DHEA-S-7kits feature ... targeted against the C-7 ... molecule, with no cross-reactivity ... Saliva RIA has been ...
Medicine Products:
(Date:3/28/2017)... Georgia (PRWEB) , ... March 28, 2017 , ... ... to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, property ... a leader in the real estate valuation industry for more than 40 years. ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Award-winning medical group Allied Anesthesia today ... board chair for Orange County health care system CalOptima Friday. CalOptima announced its ... chair Mark Refowitz’s term, which runs through June 30 of this year, until ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: